PFizer announces positive results in late-stage trial of meningococcal vaccine candidate in adolescentsMarket Watch • 09/15/22
Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in AdolescentsBusiness Wire • 09/15/22
mRNA Flu Shot Moves Forward As Pfizer Launches Late-Stage Trial, Builds On Covid Vaccine SuccessForbes • 09/14/22
Pfizer Invites Public to View and Listen to Webcast of Analyst and Investor Call to Review Oral GLP-1 Data Presented at European Association for the Study of Diabetes (EASD) 2022Business Wire • 09/14/22
Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage CancerPRNewsWire • 09/13/22
FDA and EMA Accept Regulatory Submission for Pfizer's Ritlecitinib for Individuals 12 Years and Older with Alopecia AreataBusiness Wire • 09/09/22
These Were The Five Best And Worst Performing Mega-Cap Stocks In August 202224/7 Wall Street • 09/07/22
Pfizer Inc. (PFE) Presents at Citi's 17th Annual BioPharma Brokers Conference (Transcript)Seeking Alpha • 09/07/22
FDA Grants Breakthrough Therapy Designation to Pfizer's Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant WomenBusiness Wire • 09/07/22
Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate ActionBusiness Wire • 09/06/22